Medtronic India Pvt. Ltd
The size of the Indian medical devices market is estimated at Rs. 90,000 crore (US$ 11 billion) in 2022 and is expected to grow to US$ 50 billion by 2030 with a CAGR of 16.4 %.
Medtronic India Pvt. Ltd. began operations in India in 1979. It is the wholly owned subsidiary of Medtronic Plc, an American Irish medical devices company. The company has presence across India in cities such as Mumbai, Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune, and Vadodara. Its business is categorised into four segments, namely the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). The company has research and development (R&D) facilities in Bangalore and Hyderabad.
- The total revenue of its parent company, Medtronic, stood at US$ 16.56 billion in FY24.
- Has over 95,000 employees worldwide; employs more than 1,100 people in India.
- Has presence in over 150 countries.
- 76 manufacturing facilities worldwide.
| Year | Milestone |
|---|---|
| 2024 |
In May 2024, For the second year in a row, Medtronic has achieved the second spot on Fair 360’s 2024 Top 50 Companies for Workplace Fairness, marking our highest ranking ever on this list. In April, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. |
| 2023 |
In December 2023, Medtronic announced that the United States Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). In November 2023, Medtronic announced FDA approval of minimally invasive device to treat hypertension. In May 2023, Medtronic bolsters presence in India by investing approximately Rs. 3,000 crore (US$ 362.8 million) to expand Medtronic Engineering & Innovation Center in Hyderabad. In April 2023, Medtronic India announced a partnership with Qure.ai to integrate artificial intelligence (AI) for advanced stroke management in India. |
| 2022 |
In March 2022, Medtronic India launched the MiniMed 780G system in India, which is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people between 7-80 years. |
| 2021 |
In September 2021, Medtronic India Pvt. Ltd. introduced a surgical robotics experience centre in Gurugram to help clinicians with robotic-assisted surgery technology. In September 2021, Medtronic India Private Limited collaborated with Sher-I-Kashmir Institute of Medical Sciences (SKIMS) to introduce a new surgical skills lab in Srinagar. In July 2021, Medtronic India Private Limited introduced the Percept PC Deep Brain Stimulation (DBS) system for movement disorders such as epilepsy and Parkinson’s. In June 2021, Medtronic India Private Limited announced the launch of Micra AV – a miniaturised, fully self-contained pacemaker that delivers advanced pacing technology to atrioventricular (AV) block patients via a minimally invasive approach. Launched TYRX Envelope, an absorbable, single-use, antibacterial envelope designed to stabilise a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days. |
| 2020 |
Apollo Hospitals Group announced a partnership with India Medtronic to integrate artificial intelligence (AI) for advanced stroke management for the first time in India. The USFDA-approved AI platform for stroke diagnosis has been validated by clinical trials Launched the ‘Sonicision Curved Jaw Cordless Ultrasonic Dissection System’, an ultrasonic dissection device in India. Announced an investment worth Rs. 1,200 crore (US$ 163.2 million) to expand its R&D centre for a medical device software and engineering solutions facility in Hyderabad, Telangana. |
| 2019 |
Launched the Mazor Stealth edition, a fully integrated procedural solution for surgical planning, workflow, execution, and confirmation of spine surgeries in India. Launched the ‘VenaSeal Closure System’, a minimally invasive procedure that uses a proprietary medical adhesive to close the diseased vein in patients with chronic venous disease (CVD). |
| 2018 |
Company partnered with the Cardiological Society of India to increase awareness of sudden cardiac arrests. |
| 2016 |
Announced roll-out of low-cost hip and knee programme in India. |
| 2001 |
Expanded into diabetic care category. |
| 1999 |
Expanded into spinal care category. |
| 1983 |
Expanded into the neuro-simulation category. |
| 1977 |
Introduced prosthetic heart valve. |
| 1957 |
Created the first battery-operated external pacemaker. |
| 1949 |
Company founded as a medical equipment repair shop. |
Partners
